Cite
HARVARD Citation
Davda, R. et al. (2016). Chemotherapy at First Diagnosis of Advanced Prostate Cancer – Revolution or Evolution? Findings from a British Uro-oncology Group UK Survey to Evaluate Oncologists' Views on First-line Docetaxel in Combination with Androgen Deprivation Therapy in Castrate-sensitive Metastatic and High-risk/Locally Advanced Prostate Cancer. Clinical oncology. 28 (6), pp. 376-385. [Online].